SETDB1 and acute myeloid leukemia: However, the downregulation of SETDB1 in metastatic lung cancer [12,13,115,116,117], less aggressive osteosarcomas [21] and AML [68,69,74,118,119,120] indicates SETDB1 is acting as a tumour suppressor.